T. Rowe Price Associates’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $124M | Sell |
|
|||||
|
2025
Q1 | $98.5M | Sell |
|
|||||
|
2024
Q4 | $134M | Sell |
|
|||||
|
2024
Q3 | $169M | Buy |
|
|||||
|
2024
Q2 | $188M | Buy |
|
|||||
|
2024
Q1 | $153M | Sell |
|
|||||
|
2023
Q4 | $215M | Buy |
|
|||||
|
2023
Q3 | $170M | Sell |
|
|||||
|
2023
Q2 | $157M | Sell |
|
|||||
|
2023
Q1 | $141M | Sell |
|
|||||
|
2022
Q4 | $162M | Sell |
|
|||||
|
2022
Q3 | $212M | Sell |
|
|||||
|
2022
Q2 | $557M | Buy |
|
|||||
|
2022
Q1 | $532M | Buy |
|
|||||
|
2021
Q4 | $380M | Buy |
|
|||||
|
2021
Q3 | $394M | Sell |
|
|||||
|
2021
Q2 | $489M | Sell |
|
|||||
|
2021
Q1 | $566M | Sell |
|
|||||
|
2020
Q4 | $742M | Buy |
|
|||||
|
2020
Q3 | $509M | Buy |
|
|||||
|
2020
Q2 | $508M | Buy |
|
|||||
|
2020
Q1 | $178M | Buy |
|
|||||
|
2019
Q4 | $113M | Sell |
|
|||||
|
2019
Q3 | $117M | Sell |
|
|||||
|
2019
Q2 | $128M | Sell |
|
|||||
|
2019
Q1 | $200M | Buy |
|
|||||
|
2018
Q4 | $62.1M | Buy |
|
|||||
|
2018
Q3 | $56.5M | Sell |
|
|||||
|
2018
Q2 | $50.1M | Sell |
|
|||||
|
2018
Q1 | $59.2M | Sell |
|
|||||
|
2017
Q4 | $69.8M | Buy |
|
|||||
|
2017
Q3 | $57M | Sell |
|
|||||
|
2017
Q2 | $57.9M | Sell |
|
|||||
|
2017
Q1 | $75.3M | Sell |
|
|||||
|
2016
Q4 | $90.9M | Buy |
|
|||||
|
2016
Q3 | $37.9M | Sell |
|
|||||
|
2016
Q2 | $31.2M | Buy |
|
|||||
|
2016
Q1 | $53.2M | Sell |
|
|||||
|
2015
Q4 | $86.7M | Sell |
|
|||||
|
2015
Q3 | $67.8M | Buy |
|
|||||
|
2015
Q2 | $94.9M | Buy |
|
|||||
|
2015
Q1 | $94.8M | Sell |
|
|||||
|
2014
Q4 | $165M | Sell |
|
|||||
|
2014
Q3 | $107M | Sell |
|
|||||
|
2014
Q2 | $95.3M | Sell |
|
|||||
|
2014
Q1 | $140M | Sell |
|
|||||
|
2013
Q4 | $133M | Sell |
|
|||||
|
2013
Q3 | $128M | Sell |
|
|||||
|
2013
Q2 | $103M | Buy |
|